All-Case Surveillance of Ofev in Patients With IPF in Japan

NCT02607722 · clinicaltrials.gov ↗

COMPLETED

Status

10117

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Nintedanib

Sponsor

Boehringer Ingelheim